SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2023-09-29 ms7000001846515598 来自福建省

偏重的研究方向：外科学;胃肠外科
经验分享：二审2月了，审稿人还没接稿😭

33 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2023-12-22 ms7000000881357346 来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：外科;手术
经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2023-09-15 Hello98 来自上海

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：外科学
经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2021-04-18 ms4000000885896577

请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？

61 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2023-07-19 190374007 来自江苏省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：感染
经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2020-10-03 独行er

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：胃肠外科
经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。
07/06/2020 Submitted to Journal
07/06/2020 With Editor assigned manuscript number
07/09/2020 With Editor
07/10/2020 Under Review
08/02/2020 Required Reviews Completed
08/04/2020 Revise Accept/major revision/re-review
08/13/2020 Revision Submitted to Journal
08/17/2020 Under Review
08/29/2020 Under Review
09/07/2020 Required Reviews Completed
09/15/2020 Decision in Proces
10/02/2020 Accept

1 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2022-06-01 johnnysn

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：营养;胃肠外科
经验分享：4.13 submit
5.12 require review completed
5.12 decision in progress
5.14 major revision
5.23 revision submit
5.25 under review
5.30 decision in progress
5.31 accept
最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题

70 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2023-04-06 语言的苍白来自上海

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：胸外科
经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2022-10-03 ms3000000209605964

偏重的研究方向：外科
经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了

48 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160361, encodeId=cfd62160361e6, content=偏重的研究方向：外科学;胃肠外科 经验分享：二审2月了，审稿人还没接稿😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3c8506468, createdName=ms7000001846515598, createdTime=Fri Sep 29 22:30:06 CST 2023, time=2023-09-29, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176559, encodeId=79a121e6559b3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：外科;手术 经验分享：accept/minor revise/no -re-review是什么意思，就是小修吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1be36401324, createdName=ms7000000881357346, createdTime=Fri Dec 22 15:50:38 CST 2023, time=2023-12-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157880, encodeId=ecc9215e88011, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科学 经验分享：很好的杂志，第五次中。要求比较严，感觉主编非常看中选题，对眼的即便审稿意见龊刻、甚至拒稿，编辑也会给大修；不对眼的，即便自己觉得做得很好，也会被秒拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3311365445, createdName=Hello98, createdTime=Fri Sep 15 19:42:44 CST 2023, time=2023-09-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=958013, encodeId=cf29958013a8, content=请问各位老师投了文章过后杂志发了邮件要要每个作者都确认是共同作者，请问必须需要确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41985427029, createdName=ms4000000885896577, createdTime=Sun Apr 18 12:46:44 CST 2021, time=2021-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148745, encodeId=05ab2148e4528, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：感染 经验分享：历时4个月接收，期间审稿人一直问关于实际应用问题，你只要认真回复就行了，对我的研究没有说什么意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17c54765451, createdName=190374007, createdTime=Wed Jul 19 09:39:33 CST 2023, time=2023-07-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=889894, encodeId=714588989491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胃肠外科 经验分享：贴一篇刚刚接受的文章的status供大家参考。整个过程不到3个月。 07/06/2020 Submitted to Journal 07/06/2020 With Editor assigned manuscript number 07/09/2020 With Editor 07/10/2020 Under Review 08/02/2020 Required Reviews Completed 08/04/2020 Revise Accept/major revision/re-review 08/13/2020 Revision Submitted to Journal 08/17/2020 Under Review 08/29/2020 Under Review 09/07/2020 Required Reviews Completed 09/15/2020 Decision in Proces 10/02/2020 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sat Oct 03 14:22:33 CST 2020, time=2020-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223767, encodeId=d0381223e67bf, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.13 submit 5.12 require review completed 5.12 decision in progress 5.14 major revision 5.23 revision submit 5.25 under review 5.30 decision in progress 5.31 accept 最流畅的一次投稿，一审一个月，二审5天，两个审稿人一共就提了4个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Wed Jun 01 08:11:17 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124138, encodeId=9b4b2124138b3, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：胸外科 经验分享：提交稿件第二天就给我decision in process了，太牛了，可能它比较喜欢普外科？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3c555508386, createdName=语言的苍白, createdTime=Thu Apr 06 16:34:03 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2091570, encodeId=635f20915e0c2, content=偏重的研究方向：外科 经验分享：这个杂志没落到今天不是没有理由的。之前投了liver cancer被拒稿了，转投了surgery想着这本期刊比较老，比较稳健。结果投稿3天就给我decision in process了…而且现在过了两天也没给我拒稿信。之前师姐也说过，surgery审稿很慢。而且搞不懂为何部给我送外审。可能是他们期刊比较牛吧。但是只有4分多是d级。反而被批评灌水的hbsn ijs是b级。总之以后不到万不得已肯定不会投这个杂志了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Mon Oct 03 10:26:56 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243189, encodeId=ecc21243189ec, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;外科学 经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1b5b1736627, createdName=wawljwalj9232, createdTime=Sun Sep 04 22:28:42 CST 2022, time=2022-09-04, status=1, ipAttribution=)]

2022-09-04 wawljwalj9232

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：外科;外科学
经验分享：Surgery 这本经典老牌期刊，和aso应该并驾齐驱。本身的影响力和文章已经不是所谓影响因子能够衡量的。以前as ，jama surgery ，bjs往下就是他们两个，SE偏重于微创。这几本权威期刊在国际影响力，远不是目前那些虚高的hbsn ijs hepatology international 可以媲美的

171 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务